Actively Recruiting
Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)
Led by University Hospital, Ghent · Updated on 2026-01-16
300
Participants Needed
3
Research Sites
514 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Pharmacokinetics of antibiotics in critically ill neonates, infants and children on extracorporeal membrane oxygenation (ECMO).
CONDITIONS
Official Title
Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients admitted to the pediatric intensive care unit or cardiac intensive care unit
- Patient age from 1.8 kg to 15 years
- Patient receiving antibiotic treatment with piperacillin-tazobactam, meropenem, amoxicillin-clavulanate, cefazolin, vancomycin, teicoplanin, ciprofloxacin, or amikacin
- Intra-arterial or intravenous access (other than the drug infusion line) available for blood sampling, arterial line preferred
- Extracorporeal membrane oxygenation (ECMO) circuit in use
You will not qualify if you...
- No catheter in place for blood sampling
- Absence of parental or patient consent
- Known hypersensitivity to beta-lactam antibiotics and ciprofloxacin
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Queen Fabiola Children's University Hospital
Brussels, Brussels Capital, Belgium, 1020
Actively Recruiting
2
University Hospital
Ghent, Belgium, 9000
Actively Recruiting
3
Universitair hospital
Leuven, Belgium, 3000
Actively Recruiting
Research Team
P
Pieter De Cock, PharmD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
8
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here